BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26723888)

  • 1. Ion channel profiling to advance drug discovery and development.
    Zou B
    Drug Discov Today Technol; 2015 Nov; 18():18-23. PubMed ID: 26723888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting changes in cardiac myocyte contractility during early drug discovery with in vitro assays.
    Morton MJ; Armstrong D; Abi Gerges N; Bridgland-Taylor M; Pollard CE; Bowes J; Valentin JP
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):87-94. PubMed ID: 24952337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cardiac potassium channels for state-of-the-art drug discovery.
    Walsh KB
    Expert Opin Drug Discov; 2015 Feb; 10(2):157-69. PubMed ID: 25400064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
    Dunlop J; Bowlby M; Peri R; Vasilyev D; Arias R
    Nat Rev Drug Discov; 2008 Apr; 7(4):358-68. PubMed ID: 18356919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput assay technologies for ion channel drug discovery.
    Zheng W; Spencer RH; Kiss L
    Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.
    Kraushaar U; Meyer T; Hess D; Gepstein L; Mummery CL; Braam SR; Guenther E
    Expert Opin Drug Saf; 2012 Mar; 11(2):285-98. PubMed ID: 22103746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac ion channel safety profiling on the IonWorks Quattro automated patch clamp system.
    Cao X; Lee YT; Holmqvist M; Lin Y; Ni Y; Mikhailov D; Zhang H; Hogan C; Zhou L; Lu Q; Digan ME; Urban L; Erdemli G
    Assay Drug Dev Technol; 2010 Dec; 8(6):766-80. PubMed ID: 21133679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica Nanoparticles Disturb Ion Channels and Transmembrane Potentials of Cardiomyocytes and Induce Lethal Arrhythmias in Mice.
    Liu YQ; Xue SM; Zhang P; Xu LN; Wang DP; Li G; Cao JM
    Int J Nanomedicine; 2020; 15():7397-7413. PubMed ID: 33116478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Automated Technologies to Ion Channel Drug Discovery.
    Picones A; Loza-Huerta A; Segura-Chama P; Lara-Figueroa CO
    Adv Protein Chem Struct Biol; 2016; 104():357-378. PubMed ID: 27038379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction.
    Stoelzle S; Haythornthwaite A; Kettenhofen R; Kolossov E; Bohlen H; George M; Brüggemann A; Fertig N
    J Biomol Screen; 2011 Sep; 16(8):910-6. PubMed ID: 21775699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CiPA: Ongoing testing, future qualification procedures, and pending issues.
    Cavero I; Holzgrefe H
    J Pharmacol Toxicol Methods; 2015; 76():27-37. PubMed ID: 26159293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies in ion channel screening for drug discovery: are there ways to improve its productivity?
    Farre C; Fertig N
    Expert Opin Drug Discov; 2014 Oct; 9(10):1103-7. PubMed ID: 25062795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated electrophysiology in drug discovery.
    Priest BT; Swensen AM; McManus OB
    Curr Pharm Des; 2007; 13(23):2325-37. PubMed ID: 17692004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTS techniques for patch clamp-based ion channel screening - advances and economy.
    Farre C; Fertig N
    Expert Opin Drug Discov; 2012 Jun; 7(6):515-24. PubMed ID: 22507077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel screening techniques for ion channel targeting drugs.
    Obergrussberger A; Stölzle-Feix S; Becker N; Brüggemann A; Fertig N; Möller C
    Channels (Austin); 2015; 9(6):367-75. PubMed ID: 26556400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of distribution and targeting of neuronal ion channels.
    Thayer DA; Jan LY
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):559-67. PubMed ID: 20812147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art automated patch clamp: heat activation, action potentials, and high throughput in ion channel screening.
    Stoelzle-Feix S
    Methods Mol Biol; 2014; 1183():65-80. PubMed ID: 25023302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in ion channel high throughput screening: where are we in 2023?
    Dallas ML; Bell D
    Expert Opin Drug Discov; 2024 Mar; 19(3):331-337. PubMed ID: 38108110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.